Serum Endocan as a Survival Predictor for Patients with Liver Cirrhosis
BACKGROUND: The relationship between endocan expression and outcome in patients with chronic liver disease is not fully understood.
Saved in:
Main Authors: | Nobuyuki Toshikuni, Kazuaki Ozaki, Joseph George, Mikihiro Tsutsumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2015/153805 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver Cirrhosis
by: Valeriy D. Lunkov, et al.
Published: (2019-03-01) -
Structure and Functions of Human Serum Albumin in Normal Conditions and in Patients with Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2022-12-01) -
Prognostic and Diagnostic Value of Endocan in Kidney Diseases
by: Elisabeth Samouilidou, et al.
Published: (2022-01-01) -
Serum Endocan Levels Associated with Hypertension and Loss of Renal Function in Pediatric Patients after Two Years from Renal Transplant
by: Livia Victorino de Souza, et al.
Published: (2016-01-01) -
Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature
by: Xingshun Qi, et al.
Published: (2015-01-01)